Dipyrrinato‐Iridium(III) Complexes for Application in Photodynamic Therapy and Antimicrobial Photodynamic Inactivation

Benjamin F. Hohlfeld,Burkhard Gitter,Christopher J. Kingsbury,Keith J. Flanagan,Dorika Steen,Gerhard D. Wieland,Nora Kulak,Mathias O. Senge,Arno Wiehe

DOI: https://doi.org/10.1002/chem.202004776

2021-02-09

Abstract:The generation of bio‐targetable photosensitisers is of utmost importance to the emerging field of photodynamic therapy and antimicrobial (photo‐)therapy. A synthetic strategy is presented in which chelating dipyrrin moieties are used to enhance the known photoactivity of iridium(III) metal complexes. Formed complexes can thus be functionalized in a facile manner with a range of targeting groups at their chemically active reaction sites. Dipyrrins with N‐ and O‐substituents afforded (dipy)iridium(III) complexes via complexation with the respective Cp*‐iridium(III) and ppy‐iridium(III) precursors (dipy = dipyrrinato, Cp* = pentamethyl‐η 5 ‐cyclopentadienyl, ppy = 2‐phenylpyridyl). Similarly, electron‐deficient Ir III (dipy)(ppy) 2 complexes could be used for post‐ functionalization, forming alkenyl, alkynyl and glyco‐appended iridium(III) complexes. The phototoxic activity of these complexes has been assessed in cellular and bacterial assays with and without light; the Ir III (Cl)(Cp*)(dipy) complexes and the glyco‐substituted iridium(III) complexes showing particular promise as photomedicine candidates. Representative crystal structures of the complexes are also presented.